2021 Biomedical HIV Prevention Summit Impact Report

biomedical HIV prevention

summit March 30-31, 2021 www.biomedicalhivsummit.org #2021BHPS

2021 2021 sponsor impact prospectus report

ABOUT THE SUMMIT About the Summit NMAC leads with race to urgently fight for health equity and racial justice to end the HIV epidemic in America. The Biomedical HIV Prevention Summit is the only major regular conference focused on the prevention of HIV through biomedical means. This year was the fifth conference.

Due to the COVID-19 pandemic, this year’s conference was held online instead of in person. More than 1,200 people registered to attend the conference.

Format This year’s Summit was a two-day online conference that featured four plenary sessions, an exhibit hall and 40 workshops at three levels of instruction (beginner, intermediate, and ad-vanced).

Beginner levels were primarily didactic.

Intermediate level sessions were didactic and interactive, while advanced level sessions were designed to maximize interaction between attendees and participants.

Since the Summit was held online, all plenaries and workshops are available for on demand viewing through the conference platform for 90 days after the Summit’s end.

2

2021 BIOMEDICAL HIV PREVENTION SUMMIT

OPENING PLENARY

Opening Plenary The opening plenary, “I Want Your Sex- PrEP and Claiming Power & Pleasure among GBMSM,” explored how PrEP has impacted sexual communication and behavior in an open and real conversation about sex. From academic and community perspectives, panelists shared their thoughts on the perceptions of risk, negotiation, and practices as they deepen into the liberating yet highly stigmatized aspects of PrEP. Panelists also discussed the transmascu-line experience and its impact on not only its users but also on those who are living with HIV.

2021 BIOMEDICAL HIV PREVENTION SUMMIT

3

PLENARIES Gilead Plenary Summit Presenting Sponsor Gilead offered their plenary “Evolving HIV Testing as the Entry Point to HIV Prevention,” to close day one of the Summit. Key topics explored include the cur-rent landscape of HIV testing, which includes the Ending the Epidemic plan and other initiatives, barriers, and gaps, as well as best practices highlighted through case studies.

Marlene McNeese of the Houston Health Department served as moderator of the plenary. The panel included Clover Barnes of the DC Department of Health and Dr. Leandro Mena of The University of Mississippi Medical Center.

Women’s Plenary “Pink Table Talk: Women’s Engagement and Inclusion with Biomedical Prevention Research” opened day two of the Summit. This plenary tackled the issues around the lack of inclusion cisgender women in biomedical prevention research, the limited options for HIV prevention for women, and how to address the HIV field to close these persistent gaps.

Danielle M. Campbell served as moderator to the panel which included Dr. Moupali Das of Gilead, Marissa Mercado, Dr. Kimberly Smith of ViiV Healthcare, and Celeste Watkins-Hayes, PhD, of the University of Michigan.

4

2021 BIOMEDICAL HIV PREVENTION SUMMIT

PLENARIES & WORKSHOPS Closing Plenary The Summit closed with “Biomedical HIV Prevention Technologies. Are Our Systems Ready?” This plenary focused on the new methods of biomedical HIV prevention cur-rently in the pipeline and whether or not our current health care systems will be able to provide access to them for the communities that need them.

This plenary was moderated by Allysha C. Maragh-Bass, PhD, of UCSF Center for AIDS Prevention Studies. Panelists included Edwin Corbin-Gutierrez of NASTAD, Dr. Demetre C. Daskalakis, of Centers for Disease Control and Prevention, Latisia Grant of National Association of County and City Health Officials, and Matthew Rose of the Global Access Project.

Workshops This year’s virtual summit offered over 40 workshops in the following tracks finance and access models; PrEP and ending the HIV epidemic; Training and Education Mod-els; PrEP en español; community mobilization; COVID-19 and PrEP; Women and PrEP; Health Disparities, Social Justice and PrEP; implementation Research, Evaluation, and PrEP; and the PrEP continuum of care. Additionally, the Summit offered a worked with Federal Partners to offer a Federal pathway of workshops from NIH, HRSA, and IHS.

2021 BIOMEDICAL HIV PREVENTION SUMMIT

5

WORKSHOPS & COMMUNITY The audience engaged with the presenters during the live Q&A following the presenta-tions. Over 90% of attendees said that would use the information within the next six months. More than half of the attendees stated that their knowledge level increased on the subject as a result of having attended the workshops. All workshops are available to viewing by conference attendees until the end of June 2021.

Community Corners Community Corners are a unique feature of the Summit. They are 15-minute presentation sessions from community partners on a variety of topics connected to biomedical HIV prevention. This year, there were four Community Corner sessions: Gay Men of Color - Follow up thoughts and questions from the opening plenary.

Cisgender women- Women in the PrEP era and the huge gender gap in upkeep. Aracelis Qui-ñones and Cecilia Dennis, two long-term survivors, reflected on the AIDS Epidemic of the ’80s and discussed the necessity of PrEP retention for women today.

50+ - Biomedical prevention on 50+ individuals. Steven Vargas and Michelle López discussed PrEP, sex, polypharmacy, co-occurring conditions, and more.

Transgender community corner - Biomedical prevention and transmasculine health from a pro-vider’s perspective.

6

2021 BIOMEDICAL HIV PREVENTION SUMMIT

EXHIBITORS Lounges The Summit hosted a two-day community virtual lounge during the conference. The lounge was cofacilitated by HIV community organizers and consisted of two days of fun filled activities such as yoga, art therapy, and a dance happy hour. The lounge also facilitated community sessions on Women in PrEP, Surviving HIV During an Epidemic, and a Community Trans roundtable discussion.

Exhibit Hall Every sponsor of the Summit had a booth in the Summit Virtual Exhibit Hall, offering attendees an opportunity to learn more about their services.

2021 BIOMEDICAL HIV PREVENTION SUMMIT

7

ATTENDANCE Age Range Age Range

800 800 700 700 600 600 500 500 400 400 300 300 200 200 100 100 0 0

Under 20

20-25

26-34

35-44

45-54

55-64

65+

Blank

Under 20

20-25

26-34

35-44

45-54

55-64

65+

Blank

Ethnicity Ethnicity

800 800 700 700 600 600 500 500 400 400 300 300 200 200 100 100 0 0

African American/ Black African American/ Black

American Indian/ Alaska American Native Indian/ Alaska Native

Asian

Caucasian

Asian

Caucasian

8 2021 BIOMEDICAL HIV PREVENTION SUMMIT

Latina or Hispanic Latina or Hispanic

Native Hawaiian/ Pacific Isl. Native Hawaiian/ Pacific Isl.

Non Hispanic Non Hispanic

Prefer not to disclose Prefer not to disclose

Blank Blank

ATTENDANCE

100

0

Asexual Bisexual

Gay

Hetero- Lesbian sexual

Pansexual

Other

Prefer Not to Disclose

Queer

Questioning

Same Gender Loving

Two Spirit

Blank

Other

Prefer not to disclose

Two Spirit

Blank

Gender Identity 800

700

600

500

400

300

200

100

0

Androgy- Cross Female nous Dresser

FTM to Gender Gender Trans NonQueer Man Conforming

Intersex

Male

MTF or Trans Woman

HIV Status 800

700

600

500

400

300

200

100

0

Negative

On PreP

Positive

Prefer Not to Disclose

Undeclared

Unknown

Blank

2021 BIOMEDICAL HIV PREVENTION SUMMIT

9

ATTENDANCE

Sexual Orientation 800

700

600

500

400

300

200

100

0

Asexual Bisexual

Gay

Hetero- Lesbian sexual

Pansexual

Other

Prefer Not to Disclose

Queer

Questioning

Same Gender Loving

Two Spirit

Blank

Other

Prefer not to disclose

Two Spirit

Blank

Gender Identity 800

700

600

500

400

300

200

100

0

10

Androgy- Cross Female nous Dresser

FTM to Gender Gender Trans NonQueer Man Conforming

2021 BIOMEDICAL HIV PREVENTION SUMMIT

Intersex

Male

MTF or Trans Woman

FEEDBACK Quotes & Affirmations

Brilliantly done!! Linkage

and retention to care systems in our communities are in place to help our communities achieve healthier outcomes, you have bridged a valuable support system for remarkable interventions in grass roots health and wellness, bravo!

I am inspired by your

commitment to the greater good in eradicating HIV/ AIDS stigma, I too amplify the comprehension and implementation of specific PrEP initiatives, systems should be designed to help people, not people designed to help systems.

It was a beautiful moment to

see the panel speak openly about their preferences and that it is a factor, being able to have intercourse bareback and also speaking freely about getting a load. It was beneficial to hear that speaking frankly with people works.

This workshop was amazing! The presenters were passionate about their work and extremely knowledgeable.

I just wanted to share how grateful I am for the iPad I received, as

well as the hotspot access, which allows me to fully participate in the Biomedical HIV Prevention Summit this year! I was able to view the Plenary Sessions, as well as a few workshops, even whilst being on the move yesterday! Yesterday’s sessions were nothing short of amazing, and I’m excited to see what today holds for me. Thank you, Thank you, Thank you!

2021 BIOMEDICAL HIV PREVENTION SUMMIT

11

NMAC BOARD & STAFF STAFF Executive Office Paul Kawata, Executive Director Kim Ferrell, Director of Operations Conferences Tara Barnes-Darby, Director of Conferences Alison J. McKeithen, Conferences Manager Shanta’ Gray, Conferences and Registration Coordinator

NMAC Training Center to End the Epidemic Charles Shazor Jr., Manager Gabriella Spencer, Program Coordinator Terrell Parker, Associate Program Manager Lauren Miller, Health Equity Program Coordinator Cora Trelles Cartagena, HIV Systems Coordinator Christopher Paisano, Program Coordinator – Indian Country

Communications Chip Lewis, Director of Communications Jas Florentino, Social Media Coordinator

Treatment Moisés Agosto-Rosario, Director of Treatment Damián Cabrera-Candelaria, Associate Program Manager Anthony Anderson, Program Coordinator

Finance and Administrative Division Olvin D’Souza, Director Ron Dorsey, Consultant

Government Relations Joe Huang-Racalto, Director of Government Relations & Public Policy

Development Robert York, Director of Development Diane Ferguson, Development Associate

BOARD OF DIRECTORS Chair John W. Hill, Jr., Washington, DC Co-Chair Lance Toma, San Francisco Community Health Center, San Francisco, CA

Secretary Therese Rodriguez, APICHA Community Health Center, New York, NY Treasurer Valerie Rochester, AIDS United, Washington, DC

BOARD MEMBERS Brenda Hunt Borderbelt AIDS Resource Team (BART) Lumberton, NC Monica Johnson HEROES - Helping Everyone Receive Ongoing Effective Support Columbia, LA

Rev. Ed Sanders Metropolitan Interdenominational Church Nashville, TN

Kelsey Louie, MSW, MBA Gay Men’s Health Crisis (GMHC) New York, NY

Evelyn Ullah Unique Solutions Broward County, FL

Norm Nickens San Francisco, CA

Rodolfo R. Vega JSI Research & Training Institute, Inc. Boston, MA

Leonardo Ramon Ortega, MD, MPH Shalom Health Care Center, Inc. Indianapolis, IN

12

Mario Perez County of Los Angeles Department of Public Health Office of AIDS Programs & Policy Los Angeles, CA

2021 BIOMEDICAL HIV PREVENTION SUMMIT

Carlos E. Rodríguez-Díaz, PhD, MPHE, MCHES DC CFAR Milken Institute School of Public Health, George Washington University Washington, DC

THANK YOU TO OUR SPONSORS

PRESENTING

BENEFACTOR

SUPPORTER

PARTNER

2021 BIOMEDICAL HIV PREVENTION SUMMIT

13